Plasma leptin concentration in patients with Type 2 diabetes: relationship to cardiovascular disease risk factors and insulin resistance

被引:31
|
作者
Abdella, NA
Mojiminiyi, OA
Moussa, MA
Zaki, M
Al Mohammedi, H
Al Ozairi, ESS
Al Jebely, S
机构
[1] Kuwait Univ, Fac Med, Dept Med, Safat 13110, Kuwait
[2] Kuwait Univ, Fac Med, Dept Pathol, Safat 13110, Kuwait
[3] Kuwait Univ, Fac Med, Dept Community Med, Safat 13110, Kuwait
[4] Minist Hlth, Kuwait, Kuwait
关键词
C-reactive protein; leptin; obesity; risk factors for coronary heart disease; Type 2 diabetes mellitus;
D O I
10.1111/j.1464-5491.2004.01405.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims The aim of this study was to evaluate the relationship of obesity, leptin, insulin resistance and C-reactive protein (CRP) with coronary heart disease (CHD) risk factors in patients with Type 2 diabetes mellitus (DM) with CHD compared with those with Type 2 DM without CHD. Methods Leptin, CRP (high sensitivity assay), fasting plasma insulin, glucose, HbA(1c) and full lipid profile were determined in 58 Type 2 diabetic patients with CHD and 87 Type 2 DM patients without CHD. Results were compared between those with and without CHD. Univariate correlation as well as logistic regression analyses were used to relate these markers with traditional CHD risk factors. Results Leptin showed significant correlations with BMI (r = 0.59; P less than or equal to 0.0001), waist circumference (r = 0.45; P < 0.0001), CRP (r = 0.36; P < 0.0001), and fasting insulin (r = 0.53; P < 0.0001) as well as with systolic (r = 0.23; P = 0.007) and diastolic (r = 0.23; P = 0.007) blood pressure. However, when those with and without CHD were compared only age (P < 0.0001), duration of diabetes (P < 0.001) and degree of microalbuminuria (P = 0.02) were significantly higher in patients with CHD. Leptin (P = 0.49), CRP (P = 0.19) and lipid parameters were not significantly different between the two groups. Conclusion Our study confirms a relationship between leptin and CRP with CHD risk factors. The lack of significant difference when patients with and without CHD are compared may be due to the potential confounding effects of treatment with aspirin and statins.
引用
收藏
页码:278 / 285
页数:8
相关论文
共 50 条
  • [31] Improvement of Insulin Resistance and Reduction of Cardiovascular Risk Among Obese Patients with Type 2 Diabetes with the Duodenojejunal Bypass Liner
    Hourneaux de Moura, Eduardo Guimaraes
    Bonotto Orso, Ivan Roberto
    Martins, Bruno da Costa
    Lopes, Guilherme Sauniti
    de Oliveira, Suzana Lopes
    Galvao-Neto, Manoel dos Passos
    Mancini, Marcio Correa
    Santo, Marco Aurelio
    Sakai, Paulo
    Ramos, Almino Cardoso
    Garrido-Junior, Arthur Belarmino
    Halpern, Alfredo
    Cecconello, Ivan
    OBESITY SURGERY, 2011, 21 (07) : 941 - 947
  • [32] Improvement of Insulin Resistance and Reduction of Cardiovascular Risk Among Obese Patients with Type 2 Diabetes with the Duodenojejunal Bypass Liner
    Eduardo Guimarães Hourneaux de Moura
    Ivan Roberto Bonotto Orso
    Bruno da Costa Martins
    Guilherme Sauniti Lopes
    Suzana Lopes de Oliveira
    Manoel dos Passos Galvão-Neto
    Marcio Correa Mancini
    Marco Aurélio Santo
    Paulo Sakai
    Almino Cardoso Ramos
    Arthur Belarmino Garrido-Júnior
    Alfredo Halpern
    Ivan Cecconello
    Obesity Surgery, 2011, 21 : 941 - 947
  • [33] Study of cardiovascular risk factors in Tunisian patients with recent type 2 diabetes
    Bouzid, K.
    Ben Miled, F. Ben Mami
    Hassine, M.
    Kalai, E.
    Ben Ahmed, H.
    Boujnah, R.
    Achour, A.
    Bahlous, A.
    Abdelmoula, J.
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 2012, 61 (02): : 81 - 87
  • [34] Leptin levels are not related to risk factors for coronary heart disease in patients with type 2 diabetes mellitus or normal controls
    Melidonis, A
    Iraklianou, S
    Tournis, S
    Konstandellou, I
    Tsatsoulis, A
    Foussas, S
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1999, 60 (09): : 502 - 508
  • [35] Antibodies Reactive to Leptin in Adults with Type 2 Diabetes and Its Relationship with Clinical, Metabolic and Cardiovascular Risk Parameters
    Vargas-Antillon, Ana B.
    Porchas-Quijada, Mildren
    Zepeda-Carrillo, Eloy A.
    Torres-Valadez, Rafael
    Munoz-Valle, Jose F.
    Vazquez-Solorzano, Rafael
    Valdes-Miramontes, Elia
    Hernandez-Palma, Luis A.
    Reyes-Castillo, Zyanya
    ENDOCRINE RESEARCH, 2024, 49 (01) : 12 - 21
  • [36] Relation of resistin levels with cardiovascular risk factors and insulin resistance in non-diabetes obese patients
    de Luis, D. A.
    Sagrado, M. Gonzalez
    Conde, R.
    Aller, R.
    Izaola, O.
    Perez Castrillon, J. L.
    Duenas, A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 84 (02) : 174 - 178
  • [37] Relation of resistin levels with cardiovascular risk factors, insulin resistance and inflammation in naive diabetes obese patients
    de Luis, D. A.
    Gonzalez Sagrado, M.
    Conde, R.
    Aller, R.
    Izaola, O.
    de la Fuente, B.
    Castrillon, J. L. Perez
    Romero, E.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 89 (02) : 110 - 114
  • [38] The Risk for Coronary Heart Disease According to Insulin Resistance with and without Type 2 Diabetes
    Kim, Jongoh
    Chae, Young Kwang
    Chernoff, Arthur
    ENDOCRINE RESEARCH, 2013, 38 (04) : 195 - 205
  • [39] Serum leptin levels in gastric cancer patients and the relationship with insulin resistance
    Begenik, Huseyin
    Aslan, Mehmet
    Dulger, Ahmet Cumhur
    Emre, Habib
    Kemik, Ahu
    Kemik, Ozgur
    Esen, Ramazan
    ARCHIVES OF MEDICAL SCIENCE, 2015, 11 (02) : 346 - 352
  • [40] Is "Leptin Resistance" Another Key Resistance to Manage Type 2 Diabetes?
    Salazar, Juan
    Chavez-Castillo, Mervin
    Rojas, Joselyn
    Ortega, Angel
    Nava, Manuel
    Perez, Jose
    Rojas, Milagros
    Espinoza, Cristobal
    Chacin, Maricarmen
    Herazo, Yaneth
    Angarita, Lisse
    Marcela Rojas, Diana
    D'Marco, Luis
    Bermudez, Valmore
    CURRENT DIABETES REVIEWS, 2020, 16 (07) : 733 - 749